J2794 HCPCS Level II code: Injection, risperidone (risperdal consta), 0.5 mg
J2794 is the HCPCS code for “Injection, risperidone (risperdal consta), 0.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2794Injection, risperidone (risperdal consta), 0.5 mg
Short description: Inj risperdal consta, 0.5 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2794 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2005
Where J2794 sits
- 1J codesDrugs administered other than orally
- 2Active code J2794Injection, risperidone (risperdal consta), 0.5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2794 mean?
J2794 is the HCPCS code for “Injection, risperidone (risperdal consta), 0.5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2794?
CMS lists J2794’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2794
All J codesJ2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)J2789Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 mlJ2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iuJ2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iuJ2793Injection, rilonacept, 1 mgJ2795Injection, ropivacaine hydrochloride, 1 mgJ2796Injection, romiplostim, 10 microgramsJ2797Injection, rolapitant, 0.5 mgJ2798Injection, risperidone, (perseris), 0.5 mgJ2799Injection, risperidone (uzedy), 1 mgJ2800Injection, methocarbamol, up to 10 ml